| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |